Radiother Oncol 2020 Jul 11
Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients.
Related Questions
How does the PSA change differ (if at all) compared to IMRT. Do you still use the Phoenix definition?
What do you do if PSA is slow to decline?
New comment by Radiation Oncologist at Columbia University Medical Center ( February 22, 2022)
I agree with the above approach. At the end of treatment, I also mention the possibility of a PSA bounce. So they know that it is not a single value but a trend over time that...